Genetic variants of NEIL1 are associated with RP risk through regulation of NEIL1 expression and serve as independent biomarkers for prediction of RP in patients treated with thoracic radiotherapy. This evidence concerns the gene NEIL1 and retinitis pigmentosa 1.